Two Phase 3 clinical trials testing the experimental therapy TNX-103 in people with PH-HFpEF are currently recruiting ...

Uptravi may reduce blood pressure in the lungs of children with pulmonary arterial hypertension, according to a meta-analysis ...

Columnist Mike Naple would rather be focusing on baking utensils this holiday season, but living with PH requires multiple ...

A committee has recommended an expansion of the indication for Winrevair, an approved injection therapy for adults with PAH, ...

Columnist Jen Cueva thought she had the flu, but it turned out to be much more serious. She says that with PH, life often gives you lemons.

Columnist Jolie Lizana writes about techniques she uses to keep bad feelings at bay and remember the good moments in her life ...

The FDA approved a Phase 2b trial of CS1, a new PAH therapy being tested for its impact on lung vessel resistance and ...

Constantly being attached to home medical devices is overwhelming, but columnist Anna Jeter is also grateful for the ...

People with CTEPH and higher PAWP may see fewer gains from BPA, though safety and survival remain similar, a study shows.

Having more severe chronic lung disease does not predict worse pulmonary hypertension outcomes in infants born preterm, a new ...

Scientists found altered activity of the PUM1 protein plays a key role in pulmonary hypertension development, making it a PH treatment target.

There is a range of possible pulmonary hypertension (PH) symptoms, with the most common including shortness of breath, excessive fatigue, chest pain, dizziness or fainting, racing heart, and swelling.